Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2007-08 | Page 55

# NOTES TO THE FINANCIAL STATEMENTS

**Reporting Period:** 2008  
**Reporting Currency & Multiplier:** Tk. | **Scale Multiplier:** 1.0

### 44. Other Income

| Particulars | 2008 | 2007 |
| --- | --- | --- |
| Interest Income | 735,267 | 15,169,014 |
| Exchange gain (loss) on retention quota (F.C.) accounts | - | (63,001) |
| Gain on Sale of shares in Bextex Ltd. | - | 4,448,575 |
| (Loss) / Profit on Sale of Fixed Assets (Note - 51) | (66,757) | 71,207 |
| Total | 686,510 | 19,625,795 |

### 45. Finance Cost

| Particulars | 2008 | 2007 |
| --- | --- | --- |
| Interest on Cash Credit and others | 214,066,707 | 222,581,780 |
| Interest on loan from PF and WPP/Welfare Fund | 35,587,591 | 32,160,612 |
| Total | 249,654,298 | 254,742,392 |

### 47. Income Tax Expenses

| Particulars | 2008 | 2007 |
| --- | --- | --- |
| (i) Current Tax for the year under review | 173,720,430 | 57,661,278 |
| (ii) Deferred Tax (Income)/Expense (Note 19.5) | (4,940,693) | (11,051,489) |
| Total | 168,779,737 | 46,609,789 |

### 48. Earnings Per Share (EPS)

| Particulars | 2008 | 2007 |
| --- | --- | --- |
| (a) Earnings attributable to the Ordinary Shareholders (Net profit after Tax) | 545,341,273 | 353,067,878 |
| (b) Weighted average number of Ordinary Shares outstanding during the year | 125,957,747 | 125,957,747 |
| Earnings Per Share (EPS) (Adjusted EPS of 2007) | 4.33 | 2.80 |

### 50. Related Party Disclosures

| Name of Related Parties | Nature of Transactions | Value of Transaction in 2008 | Balance at year end |
| --- | --- | --- | --- |
| (a) I & I Services Ltd. | (a) Local Delivery | 4,362,397,229 | 405,920,613 |
| (b) I & I Services Ltd. | (b) Delivery Commission | 114,180,696 | - |
| (c) Bangladesh Online Ltd. | (c) Internet Bill | 1,446,157 | - |
| (d) Beximco Holdings Ltd. | (d) Short Term Borrowing | 221,006,668 | 221,006,668 |